Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Corporate Presentation.

<< Previous

Bullboard Posts

Next >>

Comment by westcoast1000on Jan 23, 2023 6:10pm

211 Views

Post# 35240949

RE:Corporate Presentation.

Yes and thanks to fox7mf for pointing this change out.

There is a careful summary on Stocktwits of minor word changes here and there. They somewhat toned down the language.

So this was the source of all the discussion?

I wonder why the IR people did not reply earlier.

It looks like the web site had a close review by lawyers to tone it down.

<< Previous

Bullboard Posts

Next >>

Increasing summer travel could see these airline stocks soar